INFORM | First half of 2019

HARTMANN achieves moderate sales growth in the first half of 2019 The HARTMANN GROUP increased its sales revenues by 3.7% year-on-year to EUR 1,075 billion. All segments generated higher sales. The Wound Management segment developed particularly dynamically. Here the growth achieved was well above the Group average thanks to innovative wound treatment concepts. KNEIPP Group’s modern bath and body care products were another key driver behind the success. Prior-year sales exceeded in all segments In the three medical core segments, sales exceeded the prior-year value by a total of 2.8%. Together they made up 79.1% (previous year: 79.9%) of group sales. The Wound Management segment achieved a sales growth by 5.9% (organic growth: 5.8%) to EUR 242.3 million. This increase was mainly driven by superabsor- bent wound dressings and modern wound treatment products as well as the innovative HydroTherapy treat- ment concept, both of which achieved high growth rates. The personal healthcare business, which is also assigned to this segment, achieved an organic growth by 1.5%. In the Incontinence Management segment, sales increased to EUR 349.4 million, which corresponds with a change of +0.9%. Among other factors, organic growth by 1.1% was driven by an above average performance of MoliCare ® Elastic and Pull-up. Sales in the Infection Management segment in- creased by 2.5% to EUR 258.9 million. The strong per- formance was supported by the continued sales success of Sterillium ® Med as the Group’s core product for hand disinfection. With customized surgical sets and surgical gloves, the HARTMANN GROUP achieved solid sales growth in the first half of the year. Sales in the Other Group Activities segment in- creased by 7.3% to a total of EUR 224.4 million. Organic growth of 7.0% is mainly driven by solid sales of the CMC Group’s private-label products and the KNEIPP Group’s bath and body care products. The KOB Group, global market leader for special medical textiles, also achieved an increase in sales. Dynamic growth in European countries outside Germany Sales growth in the European countries outside Germany was an important growth driver in the first half of the year. Overall, the European (without Germany) region achieved an increase in sales by 4.5%. As in the previous quarter, the above average increase in sales in the central European countries (without Germany) was 6.0% and benefited from positive exchange rate effects. In Eastern Europe sales were up by 4.3%, while sales growth in Western and Southern Europe amounted to 3.2%. 4 Inform in the first half of 2019 | Business Development in the first half of 2019 Business Development in the first half of 2019 Share of total sales by business segment in EUR million and percent Wound Management 242.3 | 22.5% Incontinence Management 349.4 | 32.5% Infection Management 258.9 | 24.1% Other Group Activities 224.4 | 20.9% Share of total sales by region in EUR million and percent Germany 344.9 | 32.1% Europe excluding Germany 614.6 | 57.1% America 28.9 | 2.7% Africa, Asia, Oceania 86.6 | 8.1%